Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, April 18, 2024 · 704,748,614 Articles · 3+ Million Readers

International Cannabis Corp. Building Global Network -- CFN Media

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering International Cannabis Corp. (CSE: WRLD, OTC: KNHBF), also known as ICC, a vertically-integrated cannabis company specializing in the acquisition and operation of international cannabis assets, with the goal of creating the highest quality, lowest cost, most innovative cannabis products and facilities worldwide.

With an established presence on five continents, International Cannabis Corp. truly lives up to its name. It currently has 110 clients, representing roughly 3,500 pharmacies in 16 countries, five licenses for cultivation on three continents – including fertile agricultural land in Colombia and Greece dedicated to cannabis cultivation – and access to over 850 acres of premium hemp crops, estimated to produce up to 6,800 tons of biomass for CBD extraction.

So much has been made recently about the liberalization of cannabis regulations throughout North America that many investors have lost sight of emerging opportunities in Europe, Latin America, and Africa, enormous emerging markets with the potential to become key players in the burgeoning cannabis industry. In 2018, ICC made a series of strategic acquisitions enabling it to tap into the enormous revenue potential offered by these emerging global markets.

Please click here to see ICC’s investor presentation and get free corporate updates.

Supply Opportunities Across Europe

Europe in particular is suffering from supply shortages. The EU has a population of over 500 million, providing ICC with a unique opportunity to supply this high-growth marketplace and immediate demand. The company has an exclusive distribution agreement with Cosmos Holdings, a European based pharmaceutical distributor, to procure and distribute medical cannabis products and derivatives for clients within its trans-European distribution network. ICC intends to leverage this existing distribution to maximize revenue generation for its growing portfolio of European-based holdings.

ICC’s inaugural purchase order shows the potential for the plan. The order is for 10,000mL of THC Cannabis oil, 5,000g of dried Cannabis flower and 5,000mL of CBD oil, scheduled for distribution during the first quarter of 2019, with subsequent purchase orders expected throughout the year.

ICC’s current European holdings include:

●      EU Cannabis Corp. has been granted a medical cannabis cultivation license by the Greek government, superseding and augmenting an existing hemp license. ICC controls 16 acres in northern Greece dedicated to medical-grade cannabis cultivation, extraction, distribution, as well as R & D.

●      Polannabis Holdings controls a Polish hemp processing and extraction license and has access to over 850 acres of premium hemp crops, estimated to produce up to 6,800 tons of material for CBD extraction, as well as an existing extraction and manufacturing facility equipped with proprietary hydrocarbon extraction technologies. Poland is the sixth most populous EU member state and along with Greece, will function as ICC’s flagship European hemp cultivation and extraction hub.

●      Danavian Cannabis Ltd. controls licenses for cannabis cultivation and manufacturing in Denmark, and a 55,000 sq. foot, fully automated greenhouse facility. Danavian’s cannabis and cannabis derivatives will be sold through Denmark’s retail pharmacy network, and its industry relationships will enable future development in Scandinavia.

ICC very recently announced a definitive agreement to acquire Enigma, a Portuguese licensed cultivator, processor, and importer/exporter of hemp and hemp-derived products. Enigma currently has extensive operations in place, harvesting hemp since 2015 with plans to begin marketing CBD products in Q1 2019. ICC hopes to springboard off of the existing hemp license to secure a full spectrum cannabis license from Portugal in the coming months.

Please click here to see ICC’s investor presentation and get free corporate updates.

Latin America: The Next Big Cannabis Market

With a population of over 600 million, high rates of existing consumption, low-cost agricultural production and exports, ideal climates, a highly-skilled agricultural workforce, and warming attitudes toward legalization, Latin America is expected to establish itself as the next major cannabis market.

Canna Colombia Holdings is ICC’s Colombian subsidiary with licenses to cultivate, produce, sell and export cannabis and cannabis derivatives. It has acquired 13 hectares of optimal agricultural land located in Funza, one of the safest areas in Colombia, conveniently located within a 20-kilometre drive to Bogota’s international airport.

In October, ICC broke ground on its Colombian Cannabis Centre of Excellence, an industrial park which will serve as headquarters for the company's flagship property in Funza. The Centre forecasted to produce between 25,000 and 40,000kg of dried Cannabis flowers per year, and once fully optimized, the Colombian assets are projected to generate up to 500,000kg annually.

It will also bring together renowned growers, geneticists and service providers where new products will be developed and tested. It is ICC's belief that the COE will assist in catapulting Colombia into a world-class cannabis cultivation jurisdiction.

Strategic Partnership Produces Global Electronic Marketplace

On November 1st, ICC Cannabis announced the creation of the world’s first fully electronic cannabis marketplace through a partnership with GreenTree International, the parent company of Amercanex, which operates a secure Electronic Cannabis Market (ECM) called ACExchange. The companies will collaborate to deploy Amercanex’s revolutionary ECM across all of International Cannabis’ present and future operational jurisdictions, thereby creating the International Cannabis Exchange (“Intercanex”).

Intercanex will ensure transparency and traceability within the cannabis industry, and offers greater control of the cannabis procurement process, enabling superior pricing, improved regulatory reporting and reduced costs. The platform leverages a comprehensive suite of tools for cultivators, dispensaries, manufacturers and vendors, with the objective of fostering a neutral and fair marketplace, and will enable International Cannabis to assess product availability, facilitate real-time transactions and improve inventory management while reducing overall expenses and increasing regulatory compliance and auditability. The partnership will connect Amercanex to International Cannabis’ extensive portfolio of cultivation licenses and permits Amercanex access to ICC’s considerable distribution network.

The Upshot

ICC’s leadership team has an in-depth understanding of the cannabis and biomedical industries, as well as world-class experience within cannabis industry vehicles and derivatives, and is equipped with a suite of comprehensive solutions for emerging companies within the cannabis industry. ICC is executing and expanding at a tremendous rate, and has current operations that have not been covered here as of yet. Stay tuned for further developments as ICC implements its vision of creating a truly global cannabis company.

Please click here to see ICC’s investor presentation and get free corporate updates.

Please follow the link to read the full article: http://www.cannabisfn.com/international-cannabis-corp-building-global-network/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
flane@cannabisfn.com

 

cfn_tweakedspacing.jpg

Powered by EIN News
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release